ASSOCIATION OF DUAL ANTIPLATELET THERAPY WITH REDUCED MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE